The migraine, anxiety and depression cycle: Could CGRP inhibitors help break it?
|This webinar is organised and funded by Teva UK Limited. Views provided by speakers are their own and not necessarily shared by Teva UK Limited. Information at the meeting may discuss drug classes where Teva has a product. Prescribing information will be available at the meeting. The event is open to HCPs from the UK with an interest in headache and migraine.
https://products.tevauk.com/Ajovy_UK_PI
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard
Adverse events should also be reported to Teva UK Limited online, or telephone
0207 540 7117 or email uk.safety@tevauk.com
The Head Start programme activities are created by healthcare professionals, for healthcare professionals - designed for Consultants, Nurses, GPs and other healthcare professionals from the UK with an interest in headache and migraine
D: MIG-GB-00377 (V3.0) / M: MIG-GB-00378 (V3.0) / T: MIG-GB-00379 (V3.0) I Date of preparation: December 2024